BIB 241220 60.00P (BIB241220P60000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

BIB241220P60000

Watchlist

6.54
0.000.00%

15min DelayTrading Nov 15 13:10 ET

0.00High0.00Low

Intraday

5D
Daily

News

Capitulation in Biotech Is Near, as Well as a Rally – Piper Sandler
Seeking AlphaOct 11 11:17 ET
Why Recursion Is Getting Love as an AI and Drug Discovery Top Pick
Seeking AlphaOct 9 14:41 ET
ProShares Ultra Nasdaq Biotechnology Declares Quarterly Distribution of $0.2648
Seeking AlphaJun 26 14:57 ET
ProShares Ultra Nasdaq Biotechnology Declares Quarterly Distribution of $0.0403
Seeking AlphaMar 22 12:36 ET
ProShares Ultra Nasdaq Biotechnology Declares Quarterly Distribution of $0.0383
Seeking AlphaDec 20, 2023 12:31 ET
Private Advisor Group LLC Takes $230.80 Million Position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)
Defense WorldApr 2, 2023 04:41 ET

Comments

KellyNg9

Jan 18 03:29

$SPDR S&P Biotech ETF (XBI.US)$ $Ultra Nasdaq Biotechnology Proshares (BIB.US)$ $iShares Biotechnology ETF (IBB.US)$
moomoo.com/cour...

Invest With Cici

Jan 18 02:07

Do you have a bullish outlook on the biotech sector for 2024? Feel free to share and discuss in the comments below.🥰 $SPDR S&P Biotech ETF (XBI.US)$ $Ultra Nasdaq Biotechnology Proshares (BIB.US)$ $iShares Biotechnology ETF (IBB.US)$

Guide to biotech investing

Meltyy

Aug 25, 2022 01:54

Health Care Sector Update for 08/24/2022: SPRC,GKOS,BCDA

$Ultra Nasdaq Biotechnology Proshares (BIB.US)$ was climbing 1.5%.
$SciSparc (SPRC.US)$ rallied Wednesday, climbing over 20%, after the Israeli pharmaceuticals company said the psychedelic-based MEAI drug candidate developed with Canadian collaborator Clearmind Medicine produced a significant decrease in coccaine craving in rats compared to those in a non-treated control group during pre-clinical testing.
$Glaukos (GKOS.US)$ gained 6% after We...